Charles Rhyee

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Charles Rhyee works at COWEN and is focused on the Healthcare sector with 400 price targets and ratings documented since 2013 spanning on 26 stocks. Analyst's average stock valuation to be materialised ratio is 66.32% with an average time for price targets to be met of 286.44 days.

Most recent stock forecast was given on AMWL, American Well Corporation Class A at 23-Mar-2023.

Charles Rhyee best performing recommendations are on CSLT (CASTLIGHT HEALTH, INC).
The best stock recommendation documented was for TDOC (TELADOC HEALTH, INC) at 4/27/2020. The price target of $175 was fulfilled within 3 days with a profit of $19.89 (10.21%) receiving and performance score of 34.02.

Average potential price target upside

of $63.44 (17.24%) on HUM (HUMANA INC).
of $59 (31.72%) on CI (CIGNA CORPORATION).
of $54.21 (19.54%) on UNH (UNITEDHEALTH GROUP INCORPORATED).

Currently, out of the existing stock ratings of Charles Rhyee - 4606 which are a Hold (18.9%), 19379 which are a Buy (79.51%), 387 which are a Sell (1.59%)